Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 510 | 3,231 | 269 | 723 | 1,293 |
| Other current assets | 9 | 68 | 58 | 58 | 5 |
| TOTAL | $524 | $3,298 | $326 | $788 | $1,301 |
| Non-Current Assets | |||||
| PPE Net | 28 | 19 | 16 | N/A | N/A |
| Intangibles | 0 | 106 | 124 | 142 | 160 |
| Other Non-Current Assets | 16 | 16 | 0 | 0 | 0 |
| TOTAL | $44 | $141 | $140 | $142 | $160 |
| Total Assets | $568 | $3,439 | $466 | $930 | $1,461 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 190 | 207 | 131 | 73 | 30 |
| Accrued Expenses | 222 | 32 | N/A | N/A | N/A |
| Other current liabilities | 7,938 | 6,292 | 1,740 | 699 | 793 |
| TOTAL | $13,349 | $9,129 | $1,870 | $771 | $823 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $13,349 | $9,129 | $1,870 | $771 | $823 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 783 | 790 | 777 | 742 | 707 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | -27,377 | -19,025 | -13,207 | -2,247 | -1,683 |
| TOTAL | $-12,781 | $-5,691 | $-1,404 | $159 | $638 |
| Total Liabilities And Equity | $569 | $3,439 | $466 | $930 | $1,461 |